Carlos Taxonera Samsó

41PUBLICATIONS
152CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Jun 29, 2026
Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU.

|Oct 16, 2025
Real-World Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Retrospective Cohort Study.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Aug 08, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz

|Jul 18, 2025
Linking histological healing to quality of life: real-world insights into golimumab therapy in ulcerative colitis.

Rodrigo Galhardi Gasparini, Carlos Taxonera, Antônio José Tibúrcio Alves Júnior

|Apr 12, 2025
Real-World Effectiveness and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Systematic Review and Meta-Analysis.

Carlos Taxonera, Miguel A García-Brenes, María Machín

|Mar 15, 2025
T-cell branched glycosylation as a mediator of colitis-associated colorectal cancer progression: a potential new risk biomarker in inflammatory bowel disease.

Eduarda Leite-Gomes, Mariana C Silva, Ana M Dias

Pageof 7

Frequent Collaborators

10 joint publications

Javier P Gisbert

9 joint publications

David Olivares

7 joint publications

Cristina Alba

6 joint publications

Francisco Mesonero